1Ries LAG, Melbert D, Krapcho M,et al. SEER Cancer Statistics Review, 1975 - 2005, National Cancer Institute. Bethesda,MD, 2008, http://seer. cancer, gov/csr/1975 -2005/, based on November 2007 SEER data submission, posted to the SEER web site.
2Hreshchyshyn M. Vincristine treatment of patients with carcinoma of the uterine cervix[J]. Proc Am Assoc Cancer Res, 2007, 4 ( 29 ) : [ Ref Type : Abstract ].
3Curtin JP, Blessing JA, WebsterKD,et al. Paclitaxel, an active agent in nonsquamous carcinomas of the uterine cervix : a Gynecologic Oncology Group study[ J]. J Clin Oncol, 2001,19 (5) : 1275-1278.
4Piver MS, Lele SB, Patsner B, et al. 1.5-5 years of uninterrupted cis-diamminedichloroplatinum Ⅱ chemotherapy for metastatic cervical cancer[ J]. Gynecol Oncol, 1987, 27 (1) :24-33.
5Franckena M, De Wit R, Ansink AC, et al. Weekly systemic cisplatin plus locoregional hyperthermia: an effective treatment for patients with recurrent cervical carcinoma in a previously irradiated area[J]. Int J Hyperthermia, 2007, 23(5) :443-450.
6Long HJ, Bundy BN, Grendys EC, et al. Randomized phase Ⅲ trial of eisplatin with or without topotecan in carcinoma of the uterine cervix:a Gynecologic Oncology Group study[ J]. J Clin Oncol, 2005, 23 (21) :4626-4633.
7Kumar L, Bhargava VL. Chemotherapy in recurrent and advanced cervical cancer[J]. Gynecol Oncol, 1991,40 ( 2 ) : 107-111.
8Kigawa J, Kanamori Y, Ishihara H, et al. Response rate and cell-cycle changes due to intra-arterial infusion chemotherapy with cisplatin and bleomycin for locally recurrent uterine cervical cancer[J]. Am J Clin Oncol, 1992, 15(6) :474-479.
9Christos A, Papadimitriou, Kyrillos S, et al. Phase Ⅱ trial of paclitaxel and cisplatin in metastatic and recurrent carcinoma of the uterine cervix[J]. J Clin Oncol, 1999, 17(3) :761-766.
10Tinker AV, Bhagat K, Swenerton KD, et al. Carboplatin and paclitaxel for advanced and recurrent cervical carcinoma: the British Columbia Cancer Agency experience [J]. Gynecol Oncol, 2005, 98:54-58.
2Wang W,Jia HL,Huang JM,et al.Identification of biomarkers forlymph node metastasis in early-stage cervical cancer by tissue-based proteomics[J].Br J Cancer,2014,110(7):1748-1758.
